Zydus Lifesciences
- All
- News
-
Zydus To Develop Combination Vaccine For Shigellosis And Typhoid
Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid.
-
Zydus Gets US Regulator's Approval For Blood Pressure Medication
Zydus Lifesciences on Thursday said it received final approval from the US Food and Drug Administration (FDA) to manufacture and market Metoprolol Tartrate tablets in dosages of 25 mg, 50 mg, and 100 mg
-
Zydus Gets US Regulator's Approval To Market Generic Drug For Myxedema Coma
Zydus Lifesciences today said it has received approval from the US health regulator to market a generic product which is used to treat myxedema coma.
-
Gujarat Pharma Firm Recalls Over 55,000 Medicine Bottles From US Market
The affected lot is manufactured by Ahmedabad-based Zydus Lifesciences and marketed in the US by New Jersey-based Zydus Pharmaceuticals (USA) Inc.
-
Stocks To Watch: TCS, Eveready, Dish TV, Zydus Lifesciences
The domestic stock indices are likely to trade cautiously on Wednesday amid the ongoing Russia-Ukraine war.
-
Zydus To Develop Combination Vaccine For Shigellosis And Typhoid
Zydus Lifesciences on Tuesday said it will undertake development of a combination vaccine against shigellosis and typhoid.
-
Zydus Gets US Regulator's Approval For Blood Pressure Medication
Zydus Lifesciences on Thursday said it received final approval from the US Food and Drug Administration (FDA) to manufacture and market Metoprolol Tartrate tablets in dosages of 25 mg, 50 mg, and 100 mg
-
Zydus Gets US Regulator's Approval To Market Generic Drug For Myxedema Coma
Zydus Lifesciences today said it has received approval from the US health regulator to market a generic product which is used to treat myxedema coma.
-
Gujarat Pharma Firm Recalls Over 55,000 Medicine Bottles From US Market
The affected lot is manufactured by Ahmedabad-based Zydus Lifesciences and marketed in the US by New Jersey-based Zydus Pharmaceuticals (USA) Inc.
-
Stocks To Watch: TCS, Eveready, Dish TV, Zydus Lifesciences
The domestic stock indices are likely to trade cautiously on Wednesday amid the ongoing Russia-Ukraine war.
